FDA Investigator Sergio E Delgado
Sergio E Delgado has conducted inspections on 60 sites in 1 countries as of 08 Jul 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
60
Last Inspection Date:
08 Jul 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Sergio E Delgado:
Albert A Salvador,
Ana Delp Cintron,
Ana P Barido,
Annette Melendez,
Ashley B Jelonek,
Barbara T Carmichael,
Bonita S Chester,
Carl E Lovrich,
Cassandra L Winters,
CDR Ileana Barreto Pettit,
Christopher J Adams,
Christopher T Smith,
Clara E Santiago,
Cody D Rickman,
Colleen M Aspinwall,
Courtney A Gilbert,
David M Wilkinson,
Delkis J Caycedo,
Diane Hall,
Dianiris C Ayala,
Edwin J Gorney,
Ethan P Stegman,
Fabian Nchaparro Rodriguez,
Gabriel E Muniz,
Gail L Katz,
German Rivera,
Gisselle I Sensebe,
Heather M Bullock,
Ivan E Reyes,
Jana L Caylor,
Jennifer Lalama,
Karen M Rodriguez,
Kathleen B Swat,
Kenneth L Smalls,
Kip J Hanks,
Laura E Garcia,
Lundy H Patrick,
Lura D Baquero,
Lura D Kelly,
Mizanne E Lewis,
Nerming V Briones,
Nicole M Bell,
Omayra Nrodriguez Ruiz,
Paul A Licata,
Raymond A Lyn, Jr,
Richard J Bashay,
Ronnie E Jackson,
Sally Gopaul,
Samantha J Pinizzotto, D V M,
Shavon L Square,
Sherbet L Samuels,
Shusheen A Alexander,
Stacey A Meyer,
Stacey F Allard,
Stacey F Rivette,
Susan M Turcovski,
Thai D Truong,
Valerie Jgrecek Trinh,
Verdell Nelson,
Victor Spanioli,
William F Lagud, Jr
Sergio E Delgado's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2022 | FDA 483 | Vivex Biologics, Inc. - Form 483, 2022-08-04 |
July, 2022 | FDA 483 | Kimera Labs Inc - Form 483, 2022-07-21 |
August, 2022 | FDA 483 | Continental Services Group, Inc. - Form 483, 2022-08-24 |
September, 2023 | FDA 483 | BioStem Life Sciences - Form 483, 2023-09-15 |
December, 2023 | FDA 483 | University of Miami Infertility Center - Form 483, 2023-12-21 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more